Without stringent criteria, liver transplantation for hepatocellular carcinoma (HCC) can lead
to high cancer recurrence and poor prognosis in the current treatment context. Checkpoint …

Decreasing graft rejection and increasing graft and patient survival are great challenges
facing liver transplantation (LT). Different T cell subsets participate in the acute cellular …

Abstract Changes in recipient and donor characteristics are redefining the role of induction
in liver transplant recipients. Older recipients are more common, with greater concomitant …

Background The ability to predict which recipients will successfully complete their
posttransplant clinical course, which is crucial for liver transplant (LT) programs. The …

Background Acute rejection (AR) is an important problem after liver transplantation. We aim
to evaluate the incidence and risk factors of AR and to identify significant prognostic factors …

The use of model for end‐stage liver disease (MELD) score for liver allocation has resulted
in transplanting sicker patients. As such, it is unclear whether the risk factors and severity of …

Tacrolimus monotherapy is accepted as a feasible option during early post-liver
transplantation as per current international consensus guidelines. However, its effects in the …

Background: Corticosteroids has been the mainstay of immunosuppression (IMS) following
liver transplant (LT). With the advent of more potent IMS, complete steroid withdrawal has …

Introduction The combination of everolimus (EVR) and low-dose tacrolimus (lowTAC)
prevents T cell-mediated rejection of liver grafts as sufficiently as high-dose tacrolimus …

Tissue resident immune cells have been described in a number of different tissues including
the lungs294, skin295, uterus260, gut296 and the liver121. They are phenotypically distinct …